Abstract
The highest cancer risks in familial adenomatous polyposis (FAP) include colorectal, duodenal, and thyroid for which surveillance is recommended. Nearly all patients with FAP have gastric fundic gland polyposis (FGP), but gastric cancers are rarely reported with a similar incidence as the general population. We describe a recent, sudden increase in the incidence of gastric cancer in FAP. Seven of the ten cases were diagnosed in the last 20 months. Comparing our population to the SEER database for gastric cancer, the standardized incidence ratio is 140. All cases arose in patients with a carpeting of FGP and associated with large mounds of proximal gastric polyps. Nearly all patients were under upper endoscopic surveillance. This is a concerning observation and reflects a change in the phenotypic presentation of FAP in Western patients.
This is a preview of subscription content, log in via an institution to check access.
References
Spigelman AD, Williams CB, Talbot IC et al (1989) Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 2(8666):783–785
Jarrar AM, Milas M, Mitchell J et al (2011) Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg 252:515–521
Syngal S, Brand RE, Church JM et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110:223–262
National Comprehensive Cancer Network (2015) NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Colorectal. Version 2.2015. Fort Washington, PA: National Comprehensive Cancer Network
Vasen HFA, Moslen G, Alonso A et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704–713
Jagelman DG, DeCosse JJ, Bussey HJ (1988) Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1:1149–1150
Bianchi LK, Burke CA, Bennett AE et al (2008) Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 6:180–185
Wood LD, Salaria SN, Cruise MW, Giardiello FM, Montgomery EA (2014) Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol 38(3):389–393
Matsubara A, Sekine S, Kushima R et al (2013) Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol 229(4):579–587
Li J, Woods SL, Healey S et al (2016) Point mutations in Exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet 98:830–842
Bass AJ, Thorsson V, Shmulevich I, et al (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517):202–209
Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT (2000) Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic APC gene alterations. Am J Pathol 157:747–754
Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT (2001) Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the Β-catenin gene. Am J Pathol 158:1005–1010
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mankaney, G., Leone, P., Cruise, M. et al. Gastric cancer in FAP: a concerning rise in incidence. Familial Cancer 16, 371–376 (2017). https://doi.org/10.1007/s10689-017-9971-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-017-9971-3